Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,282.40
(
0.00%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
109.86
(
1.60%
)
Bitcoin
68,005.96
(
0.25%
)
News Focus
News Focus

Replies to post #160409 on Biotech Values

Replies to #160409 on Biotech Values
icon url

DewDiligence

05/02/13 5:33 PM

#160662 RE: oc631 #160409

GILD's Sofosbuvir + ribavirin study in Japan will enroll GT2 only (no GT3). Source: today's CC.